Pierre‐Simon Rohrlich

Centre Hospitalier Universitaire de Nice

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia”.

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia

Haematologica(2021)10.3324/haematol.2021.278697

N/A

0.489DataRank · unranked

25 citations

Joseph P. Loftus, Élodie Lainey, Aurélie Caye‐Eude, Morgane Pondrom, David A. Hottman +9 more

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

The Journal of Experimental Medicine(2021)10.1084/jem.20210554

N/A

0DataRank · unranked

307 citations

Elizaveta Orlova, Leila Sozaeva, Romain Lévy, Alyssa James, Monica M. Schmitt +60 more